Research News
View articles by month and year
1–2 of 2 articles
-
Older Women Diagnosed with DCIS or Early-Stage Disease Have Excellent Prognosis
A large study found that women older than 67 diagnosed with either DCIS or stage I breast cancer were just as likely to be alive 10 years after diagnosis as women not diagnosed with breast cancer.
-
Even Small HER2-Positive Cancers Have Higher Recurrence Risk
Small (1 cm or smaller), early-stage, HER2-positive breast cancers are more likely to come back (recur) and spread to parts of the body away from the breast (metastasize) than small, early-stage HER2-negative breast cancers, which suggests that treating these cancers with Herceptin (chemical name: trastuzumab) may make sense.
1–2 of 2 articles
